Increased levels of phospho-mTOR and two of its downstream targets, p70S6K and the eukaryotic translation factor 4E (eIF4E) have been visualized in the brains of patients with AD.36–39. This evidence concerns the gene RPS6KB1 and Alzheimer disease.